Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV001782605 | SCV002021673 | likely pathogenic | not provided | 2021-09-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002541207 | SCV003287969 | pathogenic | Peroxisome biogenesis disorder | 2022-07-23 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1324885). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with PEX6-related conditions. This sequence change creates a premature translational stop signal (p.Ser443Valfs*2) in the PEX6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX6 are known to be pathogenic (PMID: 8670792, 19877282, 21031596). This variant is not present in population databases (gnomAD no frequency). |
Baylor Genetics | RCV003475092 | SCV004201552 | likely pathogenic | Heimler syndrome 2 | 2023-07-26 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005038322 | SCV005670858 | likely pathogenic | Peroxisome biogenesis disorder 4A (Zellweger); Peroxisome biogenesis disorder 4B; Heimler syndrome 2 | 2024-04-06 | criteria provided, single submitter | clinical testing |